Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Dale

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|August 5, 2006
Lineage-specific hematopoietic growth factorsDavid C Dale, Philip S Rosenberg, Blanche P Alter
Human Gene Therapy|August 1, 2012
Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropeniaOfer Yanay, David C Dale, William R A Osborne
Hematology. American Society of Hematology. Education Program|November 10, 2001
Inherited Neutrophil Disorders: Molecular Basis and New TherapiesMary C. Dinauer, Julie A. Lekstrom-Himes, David C. Dale
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 19, 2008
Achieving a high-performance health care system: policies and positions of the American College of PhysiciansDavid C Dale, J Fred Ralston, Robert B Doherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic reviewNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.
Current Opinion in Infectious Diseases|April 20, 2002
Differential white blood cell count: underutilized or overratedDennis L. Stevens, Richard K. Root, Henry Rosen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 19, 2009
Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trialsDavid C Dale, Gordon C McCarter, Jeffrey Crawford, et al.
Breast Cancer Research and Treatment|June 18, 2013
A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative settingGary H Lyman, David C Dale, Dianne Tomita, et al.
Leukemia & Lymphoma|May 1, 2015
Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphomaGary H Lyman, Jeffrey Crawford, Dianne Tomita, et al.
Journal of Cellular Immunology|January 27, 2025
Evaluation of Neutrophil Elastase Inhibitors as Potential Therapies for <i>ELANE</i> Associated NeutropeniaVahagn Makaryan, Merideth Kelley, Audrey Anna Bolyard, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|August 5, 2006
Lineage-specific hematopoietic growth factorsDavid C Dale, Philip S Rosenberg, Blanche P Alter
Human Gene Therapy|August 1, 2012
Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropeniaOfer Yanay, David C Dale, William R A Osborne
Hematology. American Society of Hematology. Education Program|November 10, 2001
Inherited Neutrophil Disorders: Molecular Basis and New TherapiesMary C. Dinauer, Julie A. Lekstrom-Himes, David C. Dale
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 19, 2008
Achieving a high-performance health care system: policies and positions of the American College of PhysiciansDavid C Dale, J Fred Ralston, Robert B Doherty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic reviewNicole M Kuderer, David C Dale, Jeffrey Crawford, et al.
Current Opinion in Infectious Diseases|April 20, 2002
Differential white blood cell count: underutilized or overratedDennis L. Stevens, Richard K. Root, Henry Rosen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 19, 2009
Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized clinical trialsDavid C Dale, Gordon C McCarter, Jeffrey Crawford, et al.
Breast Cancer Research and Treatment|June 18, 2013
A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative settingGary H Lyman, David C Dale, Dianne Tomita, et al.
Leukemia & Lymphoma|May 1, 2015
Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphomaGary H Lyman, Jeffrey Crawford, Dianne Tomita, et al.
Journal of Cellular Immunology|January 27, 2025
Evaluation of Neutrophil Elastase Inhibitors as Potential Therapies for <i>ELANE</i> Associated NeutropeniaVahagn Makaryan, Merideth Kelley, Audrey Anna Bolyard, et al.
Pageof 15